Progress and prospects of skin gene therapy: A ten year history

Clinics in Dermatology

Volumn 23, Issue 1, 2005, Pages 107-114

  Hengge, Ulrich R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; VIRUS VECTOR;

EPIDERMOLYSIS; GENE EXPRESSION; GENE REPLACEMENT THERAPY; HUMAN; IMMUNE RESPONSE; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; REVIEW; XERODERMA PIGMENTOSUM;

EID: 13544262329     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2004.09.008     Document Type: Review

References (86)

1. U.R. Hengge, and B. Volc-Platzer The skin and gene therapy 2001 Springer Heidelberg (Germany)
2. C. Chen, and H. Okayama High-efficiency transformation of mammalian cells by plasmid DNA Mol. Cell. Biol. 7 1987 2745 2752
3. J.A. Wolff, R.W. Malone, and P. Williams Direct gene transfer into mouse muscle in vivo Science 247 1990 1465 1468
4. U.R. Hengge, E.F. Chan, and R.A. Foster Cytokine gene expression in epidermis with biological effects following injection of naked DNA Nat. Genet. 10 1995 161 166
5. E. Basner-Tschakarjan, A. Mirmohammadsadegh, and A. Baer Uptake and trafficking of DNA in keratinocytes: evidence for DNA-binding proteins Gene. Ther. 11 2004 765 774
6. M.R. Cappecchi High efficiency transformation by direct microinjection of DNA into cultured mammalian cells Cell 22 1980 479 488
7. E. Neumann, M. Schafer-Rider, and Y. Wang Gene transfer to mouse melanoma cells by electroporation in high electric fields EMBO J. 1 1982 841 845
8. J. Sanford The biolistic process Trends Biotechnol. 6 1988 299 302
9. F.L. Graham, and A.J. van der Eb A new technique for the assay of infectivity of human adenovirus 5 DNA Virology 52 1973 456 467
10. J.H. Felgner, T.R. Gadek, and M. Holm Lipofection: a highly efficent, lipid-mediated DNA-transfection procedure Proc. Natl. Acad. Sci. U. S. A. 84 1987 7413 7417
11. O. Boussif, F. Lezoualc'h, and M.A. Zanta A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. U. S. A. 92 1995 7297 7301
12. P.L. Felgner, Y. Barenholz, and J.P. Behr Nomenclature for synthetic gene delivery systems Human Gene. Ther. 8 1997 511 512
13. E. Wagner, M. Zenke, and M. Cotten Transferrin-polycation conjugates as carriers for DNA uptake into cells Proc. Natl. Acad. Sci. U. S. A. 87 1990 3410 3414
14. U.R. Hengge, P.S. Walker, and J.C. Vogel Expression of naked DNA in human, pig and mouse skin J. Clin. Invest. 97 1996 2911 2916
15. J.M. Davidson, T. Krieg, and S.A. Eming Particle-mediated gene therapy of wounds Wound Repair Regen. 8 2000 452 459
16. N. Raghavachari, and W.E. Fahl Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles J. Pharm. Sci. 91 2002 615 622
17. L. Li, and R.M. Hoffman The feasibility of targeted selective gene therapy of the hair follicle Nat. Med. 1 1995 705 706
18. H. Fan, Q. Lin, and G.R. Morrissey Immunization via hair follicles by topical application of naked DNA to normal skin Nat. Biotechnol. 17 1999 870 872
19. A. Domashenko, S. Gupta, and G. Cotsarelis Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex Nat. Biotechnol. 18 2000 420 423
20. M.L. Sikes, B.W. O'Malley Jr., and M.J. Finegold In vivo gene transfer into rabbit thyroid follicular cells by direct DNA injection Hum. Gene. Ther. 5 1994 837 844
21. J. Yovandich, B. O'Malley Jr., and M. Sikes Gene transfer to synovial cells by intra-articular administration of plasmid DNA Hum. Gene. Ther. 6 1995 603 610
22. T. Takehara, N. Hayashi, and M. Yamamoto In vivo gene transfer and expression in rat stomach by submucosal injection of plasmid DNA Hum. Gene. Ther. 7 1996 589 593
23. R. Stribling, E. Brunette, and D. Liggitt Aerosol gene delivery in vivo Proc. Natl. Acad. Sci. U. S. A. 89 1992 11277 11281
24. K.B. Meyer, M.M. Thompson, and M.Y. Levy Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics Gene. Ther. 2 1995 450 460
25. U.R. Hengge, B. Dexling, and A. Mirmohammadsadegh Safety and pharmacokinetics of naked plasmid DNA in the skin: studies on dissemination and ectopic expression J. Invest. Dermatol. 116 2001 979 982
26. U.R. Hengge, and D. Schadendorf Modification of melanoma cells via ballistic gene delivery for vaccination Lasic Templeton Gene Therapy: Therapeutic mechanisms and strategies 2000 Marcel Dekker New York 165 180
27. U.R. Hengge, L.B. Taichman, and P. Kaur How realistic is cutaneous gene therapy? Exp. Dermatol. 8 1999 419 431
28. B. Lu, H.J. Federoff, and Y. Wang Topical application of viral vectors for epidermal gene transfer J. Invest. Dermatol. 108 1997 803 808
29. D.C. Tang, Z. Shi, and D.T. Curiel Vaccination onto bare skin Nature 388 1997 729 730
30. S. Ghazizadeh, and L.B. Taichman Virus-mediated gene transfer for cutaneous gene therapy Hum. Gene. Ther. 11 2000 2247 2251
31. J. Bramson, K. Dayball, and C. Evelegh Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines Gene. Ther. 10 2003 251 260
32. H. Deng, Q. Lin, and P.A. Khavari Sustainable cutaneous gene delivery Nat. Biotechnol. 15 1997 1388 1391
33. T.M. Kolodka, J.A. Garlick, and L.B. Taichman Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes Proc. Natl. Acad. Sci. U. S. A. 95 1998 4356 4361
34. S. Ghazizadeh, R. Harrington, and L. Taichman In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy Gene. Ther. 6 1999 1267 1275
35. B.A. Donahue, J.G. McArthur, and S.K. Spratt Selective uptake and sustained expression of AAV vectors following subcutaneous delivery J. Gene. Med. 1 1999 31 42
36. U.R. Hengge, and A. Mirmohammadsadegh Adeno-associated virus expresses transgenes in hair follicles and epidermis Mol. Ther. 2 2000 188 194
37. S.C. Baek, Q. Lin, and P.B. Robbins Sustainable systemic delivery via a single injection of lentivirus into human skin tissue Hum. Gene. Ther. 12 2001 1551 1558
38. U. Kuhn, A. Terunuma, and W. Pfutzner In vivo assessment of gene delivery to keratinocytes by lentiviral vectors J. Virol. 76 2002 1496 1504
39. T.G. Jensen, D.M. Sullivan, and R.A. Morgan Retrovirus-mediated gene transfer of ornithine- delta-aminotransferase into keratinocytes from gyrate atrophy patients Hum. Gene. Ther. 8 1997 2125 2132
40. R. Christensen, U.B. Jensen, and T.G. Jensen Skin genetically engineered as a bioreactor or a 'metabolic sink' Cells Tissues Organs 172 2002 96 104
41. K.A. Choate, D.A. Medalie, and J.R. Morgan Corrective gene transfer in the human skin disorder lamellar ichthyosis Nat. Med. 2 1996 1263 1267
42. R.A. Freiberg, K.A. Choate, and H. Deng A model of corrective gene transfer in X-linked ichthyosis Hum. Mol. Genet. 6 1997 927 933
43. S.H. Compton, S. Mecklenbeck, and J.E. Mejia Stable integration of large (>100 kb) PAC constructs in HaCaT keratinocytes using an integrin-targeting peptide delivery system Gene. Ther. 7 2000 1600 1605
44. S. Ortiz-Urda, Q. Lin, and C.L. Green Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue J. Clin. Invest. 111 2003 251 255
45. J. Vailly, L. Gagnoux-Palacios, and E. Dell'Ambra Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia Gene. Ther. 5 1998 1322 1332
46. C.S. Seitz, G.J. Giudice, and S.D. Balding BP180 gene delivery in junctional epidermolysis bullosa Gene Ther. 6 1999 42 47
47. E. Dellambra, J. Vailly, and G. Pellegrini Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa Hum. Gene. Ther. 9 1998 1359 1370
48. P.B. Robbins, Q. Lin, and J.B. Goodnough In vivo restoration of laminin 5 β3 expression and function in junctional epidermolysis bullosa Proc. Natl. Acad. Sci. U. S. A. 98 2001 5193 5198
49. E. Dellambra, S. Prislei, and A.L. Salvati Gene correction of integrin beta4-dependent pyloric atresia-junctional epidermolysis bullosa keratinocytes establishes a role for beta4 tyrosines 1422 and 1440 in hemidesmosome assembly J. Biol. Chem. 276 2001 41336 41342
50. K. Kraemer, M. Lee, and J. Scotto Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases Arch. Dermatol. 123 1987 241 250
51. J.K. Kim, D. Patel, and B.S. Choi Contrasting structural impacts induced by cis-syn cyclobutane dimer and (6-4) adduct in DNA duplex decamers: Implication in mutagenesis and repair activity Photochem. Photobiol. 62 1995 44 50
52. C. Arnaudeau-Begard, F. Dargent-Brélier, and O. Chevallier-Lagente Genetic correction of DNA repair deficient/cancer prone xeroderma pigmentosum group C keratinocytes Hum. Gene Ther. 14 2003 983 996
53. T. Tumbar, G. Guasch, and V. Greco Defining the epithelial stem cell niche in skin Science 303 2004 359 363
54. S. Ghazizadeh, C. Doumeng, and L.B. Taichman Durable and stratum-specific gene expression in epidermis Gene. Ther. 9 2002 1278 1285
55. M.J. Arin, M.A. Longley, and X.J. Wang Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders J. Cell Biol. 152 2001 645 649
56. M. Chen, N. Kasahara, and D.R. Keene Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa Nat. Genet. 32 2002 670 675
57. Z. Ivics, P.B. Hackett, and R.H. Plasterk Molecular reconstruction of Sleeping Beauty, a Tc1- like transposon from fish, and its transposition in human cells Cell 91 1997 501 510
58. S.R. Yant, L. Meuse, and W. Chiu Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system Nat Genet 25 2000 35 41
59. S. Ortiz-Urda, Q. Lin, and S.R. Yant Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer Gene. Ther. 10 2003 1099 1104
60. S. Ortiz-Urda, B. Thyagarajan, and D.R. Keene Stable nonviral genetic correction of inherited human skin disease Nat. Med. 8 2002 1166 1170 [Erratum in: Nat Med 2003;9:237]
61. W. Pfutzner, A. Terunuma, and C.L. Tock Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo Proc. Natl. Acad. Sci. U.S.A. 99 2002 13096 13101
62. E.A. Burton, and K.E. Davies Muscular dystrophy-reason for optimism? Cell 108 2002 5 8
63. Y. Saeki, M. Wataya-Kaneda, and K. Tanaka Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes Gene. Ther. 5 1998 1031 1037
64. Y. Kaneda, Y. Saeki, and M. Nakabayashi Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector Hum. Gene Ther. 11 2000 471 479
65. J.K. Tyler, and J.T. Kadonaga The "dark side" of chromatin remodeling: repressive effects on transcription Cell 99 1999 443 446
66. W.Y. Chen, E.C. Bailey, and S.L. McCune Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase Proc. Natl. Acad. Sci. U. S. A. 94 1997 5798 5803
67. L.D. Dion, K.T. Goldsmith, and D.C. Tang Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase Virology 231 1997 201 209
68. T. Yamano, K. Ura, and R. Morishita Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase Mol. Ther. 1 2000 574 580
69. Magnaldo T, Sarasin A. Use of the CD24 marker gene for the selection of keratinocytes stem cells transformed by exogenous sequences. January 16th 2003. WO 03/004655 A2.
70. S.M. Elbashir, J. Martinez, and A. Patkaniowska Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate EMBO J. 20 2001 6877 6888
71. J. Capodici, K. Karikó, and D. Weissman Inhibition of HIV-1 infection by small interfering RNA- mediated RNA interference J. Immunol. 169 2002 5196 5201
72. R.R. Laposa, L. Feeney, and J.E. Cleaver Recapitulation of the cellular xeroderma pigmentosum- variant phenotypes using short interfering RNA for DNA polymerase H Cancer Res. 63 2003 3909 3912
73. S. Ghazizadeh, R.S. Kalish, and L.B. Taichman Immune-mediated loss of transgene expression in skin: implications for cutaneous gene therapy Mol. Ther. 7 2003 296 303
74. R.L. Ng, B. Woodward, and S. Bevan Retroviral marking identifies grafted autologous keratinocytes in porcine wounds receiving cultured epithelium J. Invest. Dermatol. 108 1997 457 462
75. E. Raz, H. Tighe, and Y. Sato Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization Proc. Natl. Acad. Sci. U. S. A. 93 1996 5141 5145
76. A.T. Larregina, and L.D. Falo Jr. Generating and regulating immune responses through cutaneous gene delivery Hum. Gene. Ther. 11 2000 2301 2305
77. F. Mingozzi, Y.L. Liu, and E. Dobrzynski Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer J. Clin. Invest. 111 2003 1347 1356
78. M. Ohyama, T. Ota, and M. Aoki Suppression of the immune response against exogenous desmoglein 3 in desmoglein 3 knockout mice: an implication for gene therapy J. Invest. Dermatol. 120 2003 610 615
79. L. Pulkkinen, M.P. Marinkovich, and H.T. Tran Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa J. Invest. Dermatol. 113 1999 1114 1118
80. G. Dallinger, M. Puttaraju, and L.G. Mitchell Development of spliceosome-mediated RNA trans-splicing (SMaRT) for the correction of inherited skin diseases Exp. Dermatol. 12 2003 37 46
81. V. Alexeev, O. Igoucheva, and K. Yoon Simultaneous targeted alteration of the tyrosinase and c-kit genes by single-stranded oligonucleotides Gene. Ther. 9 2002 1667 1675
82. V. Alexeev, O. Igoucheva, and A. Domashenko Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide Nat. Biotechnol. 18 2000 43 47
83. M.R. Capecchi The new mouse genetics: altering the genome by gene targeting Trends Genet. 5 1989 70 76
84. R.J. Yanez, and A.C. Porter Therapeutic gene targeting Gene. Ther. 5 1998 149 159
85. T. Cao, M.A. Longley, and X.J. Wang Inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy J. Cell. Biol. 152 2001 651 656
86. M. Kashani-Sabet Ribozyme therapeutics J. Investig. Dermatol. Symp. Proc. 7 2002 76 78